Analysts/Institutional Investor Meet/Con. Call Updates

**Headline: Dr. Agarwal's Health Care Limited Announces Earnings Call for Q2 FY 2025-26** Dr. Agarwal’s Health Care Limited (BSE: 544350, NSE: AGARWALEYE) has officially announced an earnings confere

28 October 2025
5 min read

Headline: Dr. Agarwal's Health Care Limited Announces Earnings Call for Q2 FY 2025-26

Dr. Agarwal’s Health Care Limited (BSE: 544350, NSE: AGARWALEYE) has officially announced an earnings conference call scheduled for Friday, October 31, 2025, from 11:30 AM to 12:30 PM IST. This call will provide insights into the unaudited financial results for the quarter and half-year ended September 30, 2025.

The conference will feature key executives, including Dr. Adil Agarwal, Whole-time Director and CEO; Mr. Yashwanth Venkat, Chief Financial Officer; and Ms. Aashna Dharia, Head of Investor Relations. They will discuss the company's performance, strategies, and future outlook, making it a must-attend for investors and analysts keen on understanding the company's trajectory.

Investors can join the call by dialing in at the following numbers: - India: +91 22 6280 1308 / +91 22 7115 8161 - International Toll-Free: Available for several countries including the USA, UK, Canada, and Australia.

To enhance the experience, participants are encouraged to join 10 minutes early and can register for a Diamond Pass for priority access via [this link](https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=1408248&linkSecurityString=acd826168).

For more details on the earnings call, visit the [official website](https://dragarwals.co.in/dr-agarwals-health-care/#analyst-earnings-call).

Stay tuned for insights from one of the leading health care providers in India as they navigate the evolving landscape of the health sector. Don't miss this opportunity to gain valuable information that could impact your investment decisions!